eHealth Report: AI Usage and GLP-1 Coverage Surge in 2027 Medicare Enrollment
A mid-term report from eHealth (Nasdaq: EHTH) regarding the Medicare Annual Enrollment Period reveals a significant shift in consumer behavior, with 75% of beneficiaries using AI tools to review their 2027 plan options. Despite this technological adoption, licensed insurance agents remain the most trusted resource for 50% of those reviewing plans. A major highlight is the massive increase in GLP-1 drug coverage; 93% of Medicare Advantage plans offered by eHealth now include at least one obesity treatment drug, up from just 5% in 2026. However, cost concerns persist as 63% of beneficiaries expressed surprise at high monthly premiums and an 8% increase in average out-of-pocket maximums. The report also notes a trend in plan structure changes, with the availability of Part B premium refund benefits dropping from 32% in 2026 to 20% for 2027 plans. While consumer optimism regarding healthcare access is high following recent elections, many enrollees face disruptions, including 69% needing to change doctors due to plan shifts.

Tickers: $EHTH
Topics: AI in insurance selection GLP-1 drug coverage Healthcare affordability Medicare Advantage